Roche records 8% increase in group sales for H1 2021
Sales in the Pharmaceuticals Division dropped by 3% in H1 2021 due to the impact of biosimilars.
Market Data
Johnson & Johnson reports 27.1% increase in Q2 2021 sales
The company expects $2.5bn to $3.3bn in global sales from its Covid-19 vaccine this year.
Our exclusive database of multinational pharmaceutical companies and their subsidiaries
The world’s leading pharmaceutical companies operate an average of 105.1 subsidiaries each. We reveal the...
STADA to acquire 16 consumer healthcare brands from Sanofi
The transaction does not cover manufacturing assets and employees related to the brands.
How is activity in the pharma sector recovering from Covid-19’s impact?
Analysis of jobs, deals, stock prices and financial filings and news sentiments now show pharma...
Takeda Pharmaceutical reports decline in FY2020 revenue
Takeda meets FY2020 management guidance and records a 2.8% decline in reported revenue.
Novo Nordisk reports increased Q1 2021 profit
Novo Nordisk has reported a net profit of kr12.6bn ($2.03bn) for the first quarter (Q1) of 2021, which represents an increase of 6% compared to kr11.9bn ($1.92bn) in Q1 2020.
Pfizer forecasts $26bn of Covid-19 vaccine revenue after first-quarter success
According to the first-quarter results published by Pfizer this week, its coronavirus jab has reaped revenues of $3.5bn for the biopharma giant in the first three months of 2021.
Pfizer’s Covid-19 vaccine sales boost revenue in Q1 2021
Pfizer has increased 2021 financial guidance for its Covid-19 vaccine candidate BNT162b2 after the product generated $3.5bn in global revenues during the first quarter (Q1) of this year.
Global rheumatologists’ biosimilar prescription rates shift from 2018 to 2020
The rate of biosimilar adoption for the treatment of autoimmune diseases varies greatly by geographical market.
Over 50% of all chronic hepatitis B cases go undiagnosed in the 9MM
Chronic hepatitis B (CHB) is a viral liver disease that develops when the immune system cannot fight the hepatitis B virus and it remains in the body for six months or longer.
